These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Did Reduced Alveolar Delivery of Surfactant Contribute to Negative Results in Adults with Acute Respiratory Distress Syndrome? Grotberg JB; Filoche M; Willson DF; Raghavendran K; Notter RH Am J Respir Crit Care Med; 2017 Feb; 195(4):538-540. PubMed ID: 28199167 [No Abstract] [Full Text] [Related]
5. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer? Chima RS; Zingarelli B Crit Care Med; 2007 Oct; 35(10):2442-3. PubMed ID: 17885382 [No Abstract] [Full Text] [Related]
6. [Surfactant update. International Symposium on current aspects and developments]. Z Geburtshilfe Neonatol; 1995; 199(6 Suppl):1-16. PubMed ID: 9022404 [No Abstract] [Full Text] [Related]
7. Pre- and postnatal factors in chronic lung disease: implications for management. Martin RJ; Walsh MC Paediatr Respir Rev; 2004; 5 Suppl A():S235-40. PubMed ID: 14980277 [No Abstract] [Full Text] [Related]
11. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome. Merritt TA; Hallman M; Spragg R; Heldt GP; Gilliard N Drugs; 1989 Oct; 38(4):591-611. PubMed ID: 2684594 [TBL] [Abstract][Full Text] [Related]
12. Surfactant: current and potential therapeutic application in infants and adults. Lewis J; Veldhuizen RA J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204 [TBL] [Abstract][Full Text] [Related]